Table 4. Analysis of related high-risk factors in A1GDM group and A2GDM group.
| Factors | A1GDM group (n=171) | A2GDM group (n=23) | P value |
|---|---|---|---|
| Age (year) | 31.57±3.67 | 32.70±3.17 | 0.35 |
| Pre pregnancy BMI (kg/m2) | 21.64±2.35 | 22.43±3.24 | 0.44 |
| BMI at middle stage (kg/m2) | 24.67±2.73 | 25.79±3.73 | 0.43 |
| BMI at late stage (kg/m2) | 26.93±2.87 | 27.72±4.18 | 0.38 |
| OGTT0h (mmol/L) | 4.76±0.48 | 5.31±0.70 | <0.01 |
| OGTT1h (mmol/L) | 9.46±1.50 | 10.21±1.96 | 0.1 |
| OGTT2h (mmol/L) | 7.93±1.94 | 9.24±1.88 | 0.02 |
| FINS at middle stage (mU/L) | 22.93±3.76 | 22.61±3.55 | 0.7 |
| FINS at late stage (mU/L) | 24.52±3.40 | 23.24±3.48 | 0.09 |
| RBP4 at middle stage (mg/mL) | 41.18±7.31 | 40.47±7.04 | 0.66 |
| RBP4 at late stage (mg/mL) | 43.73±7.12 | 41.74±7.09 | 0.21 |
| HOMA-IR at middle stage | 4.84±0.91 | 5.30±0.93 | 0.02 |
| HOMA-IR at late stage | 5.04±0.97 | 5.45±1.95 | 0.76 |
| FPG at late stage (mmol/L) | 4.62±0.55 | 5.26±1.51 | 0.03 |
BMI, body mass index; FPG, fasting plasma glucose; FINS, fasting insulin; RBP4, retinol-binding protein 4; GDM, gestational diabetes mellitus; HOMA-IR, insulin resistance index.